The primary goal of this proposal is to characterize proinflammatory cytokines TNF and IL-1 activated signal transduction in vascular endothelial cells (EC) to identify unique TNF-mediated pathways in inflammation. Inflammation is a process essential for host defense and tissue repair. However, defense may cause pathogenic changes leading to vascular diseases such as atherosclerosis. TNF triggers survival signal via activation of NF-kappaB, inflammation (and apoptosis) via activation of JFK. The major hypothesis of this proposal is that inhibition of JNK without disruption of NF-kappaB activation would provide a valid approach for anti-inflammatory therapy. We have elucidated that different proinflammatory cytokines activate unique as well as common intracellular signaling pathways as demonstrated by homologous desensitization (HMD) and heterologous desensitization (HTD). EC pre-treated with TNF become refractory to TNF restimulation but can be restimualted by IL-1 to active JNK and express E-selectin and vice versa (i.e. JNK activation and E-selectin expression show homologous desensitization - HMD). In contrast, atheroprotective laminar flow inhibits both TNF and IL-1-induced JNK and adhesion molecules (heterologous desensitization-HTD). We believe that HMD modulates a cytokine-specific inflammation, whereas HTD modulates all-cytokine-induced inflammation. We will use HMD and HTD as models to dissect TNF-activated JNK activation from NF-kappaB and from IL-1 signaling pathway. The specific hypothesis to be investigated is that: 1). HMD is via TNF receptor-associated factor 2 (TRAF2), an adaptor protein in TNF signaling as a bifurcation point for JNK and NF-kappaB. 2). HTD is via the MAP kinase kinase kinase ASK1, a convergent point of TNF and IL-1 signaling in EC. Exciting preliminary data indicate that overexpression of TRAF2 in EC desensitizes TNF-induced JNK and E-selectin, and that the specific domains and the natural cleavage products of TRAF2 play roles in JNK activation.
Three specific aims are proposed. 1). HMD is via TRAF2 focusing on characterizing TRAF2 unique residues, binding proteins and cleavage products in JNK activation. 2) HTD is via ASK1 focusing on characterizing flow effect on TNF and IL-1-induced ASK lactivation. 3) Characterizing roles of TRAF2 and ASK1 in TNF-induced inflammation in murine models by gene delivery of TRAF2 or ASK1 into cornea endothelium. This proposal should provide candidate proteins that are specific or unique targets for TNF-mediated inflammatory events and facilitate development of new therapeutic approaches to control inflammation in various disease settings.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL065978-01
Application #
6189266
Study Section
Pathology A Study Section (PTHA)
Program Officer
Collier, Elaine S
Project Start
2000-08-01
Project End
2004-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$300,258
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Zhou, Huanjiao Jenny; Chen, Xiaodong; Huang, Qunhua et al. (2014) AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses. Arterioscler Thromb Vasc Biol 34:603-15
Huang, Qunhua; Qin, Lingfeng; Dai, Shengchuan et al. (2013) AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Arterioscler Thromb Vasc Biol 33:795-804
Wan, Ting; Xu, Zhe; Zhou, Huanjiao Jenny et al. (2013) Functional analyses of TNFR2 in physiological and pathological retina angiogenesis. Invest Ophthalmol Vis Sci 54:211-21
Jones, Dennis; Li, Yonghao; He, Yun et al. (2012) Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis. Arterioscler Thromb Vasc Biol 32:633-42
Ji, Weidong; Li, Yonghao; Wan, Ting et al. (2012) Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling. Arterioscler Thromb Vasc Biol 32:2271-9
Yu, Luyang; Qin, Lingfeng; Zhang, Haifeng et al. (2011) AIP1 prevents graft arteriosclerosis by inhibiting interferon-?-dependent smooth muscle cell proliferation and intimal expansion. Circ Res 109:418-27
Min, Wang; Pober, Jordan S (2011) AIP1 in graft arteriosclerosis. Trends Cardiovasc Med 21:229-33
Wan, Ting; Liu, Ting; Zhang, Haifeng et al. (2010) AIP1 functions as Arf6-GAP to negatively regulate TLR4 signaling. J Biol Chem 285:3750-7
Luo, Yan; Xu, Zhe; Wan, Ting et al. (2010) Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 30:1307-14
Yu, Luyang; Ji, Weidong; Zhang, Haifeng et al. (2010) SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis. J Exp Med 207:1183-95

Showing the most recent 10 out of 35 publications